Literature DB >> 22249697

[Laser ablation. Do we still need it?].

C Rosenberg1, C O M Hoffmann, B Mensel, R Puls, N Hosten.   

Abstract

Laser ablation (LA) is momentarily the only invasive ablation procedure besides radiofrequency ablation (RFA) which can be performed entirely under magnetic resonance imaging (MRI) guidance. The long-term outcome and morbidity profiles are broadly identical for both modalities, excluding the RFA-specific prevalence for skin burns. The technical and logistic disadvantages of LA have been overcome since the introduction of miniaturized two-component applicators. The main advantage of LA is its superior MRI compatibility. Interference-free imaging during LA allows MR thermometric real-time therapy control without the need for RF filters. High-resolution thermometry in the target zone only makes sense without the extinction artifact of a metal probe and this condition is met only by the glass fibers of LA. An independent therapy monitoring is crucial in modern scenarios of oncologic quality management.

Mesh:

Year:  2012        PMID: 22249697     DOI: 10.1007/s00117-011-2207-x

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  37 in total

1.  Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients.

Authors:  T C Chua; A Sarkar; A Saxena; D Glenn; J Zhao; D L Morris
Journal:  Ann Oncol       Date:  2010-03-24       Impact factor: 32.976

2.  Radiofrequency ablation of small liver malignancies under magnetic resonance guidance: progress in targeting and preliminary observations with temperature monitoring.

Authors:  Sylvain Terraz; Alexandru Cernicanu; Matthieu Lepetit-Coiffé; Magalie Viallon; Rares Salomir; Gilles Mentha; Christoph D Becker
Journal:  Eur Radiol       Date:  2009-09-16       Impact factor: 5.315

3.  [Resection of lung metastases: long-term results and prognostic analysis based on 5206 cases--the International Registry of Lung Metastases].

Authors:  G Friedel; U Pastorino; M Buyse; R J Ginsberg; P Girard; P Goldstraw; M Johnston; P McCormack; H Pass; J B Putnam; H Toomes
Journal:  Zentralbl Chir       Date:  1999       Impact factor: 0.942

4.  Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan.

Authors:  Koichiro Yamakado; Soichiro Hase; Toshiyuki Matsuoka; Noboru Tanigawa; Atsuhiro Nakatsuka; Haruyuki Takaki; Motoshi Takao; Yoshihiro Inoue; Susumu Kanazawa; Yuichi Inoue; Satoshi Sawada; Masato Kusunoki; Kan Takeda
Journal:  J Vasc Interv Radiol       Date:  2007-03       Impact factor: 3.464

Review 5.  Phototherapy in tumors.

Authors:  S G Bown
Journal:  World J Surg       Date:  1983-11       Impact factor: 3.352

6.  Residual tumor after laser ablation of human non-small-cell lung cancer demonstrated by ex vivo staining: correlation with invasive temperature measurements.

Authors:  Christian Oliver Martin Hoffmann; Christian Rosenberg; Albert Linder; Norbert Hosten
Journal:  MAGMA       Date:  2011-06-09       Impact factor: 2.310

7.  Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.

Authors:  Caroline J Simon; Damian E Dupuy; Thomas A DiPetrillo; Howard P Safran; C Alexander Grieco; Thomas Ng; William W Mayo-Smith
Journal:  Radiology       Date:  2007-04       Impact factor: 11.105

8.  Laser ablation of liver metastases from colorectal cancer with MR thermometry: 5-year survival.

Authors:  Ralf Puls; Soenke Langner; Christian Rosenberg; Katrin Hegenscheid; Jens Peter Kuehn; Kai Noeckler; Norbert Hosten
Journal:  J Vasc Interv Radiol       Date:  2008-12-24       Impact factor: 3.464

9.  Hepatectomy and lung radiofrequency ablation for hepatic and subsequent pulmonary metastases from colorectal carcinoma.

Authors:  Tristan D Yan; Julie King; Ardalan Ebrahimi; Adrian Sjarif; Derek Glenn; Karin Steinke; David L Morris
Journal:  J Surg Oncol       Date:  2007-10-01       Impact factor: 3.454

10.  Long-term outcome of cirrhotic patients with early hepatocellular carcinoma treated with ultrasound-guided percutaneous laser ablation: a retrospective analysis.

Authors:  Claudio Maurizio Pacella; Giampiero Francica; Francesca Marta Lilja Di Lascio; Vincenzo Arienti; Ettore Antico; Bruno Caspani; Fabrizio Magnolfi; Angelo Salomone Megna; Stefano Pretolani; Renato Regine; Massimo Sponza; Roberto Stasi
Journal:  J Clin Oncol       Date:  2009-03-30       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.